Landmark trial reduces radiation for breast cancer treatment
07 December 2023
A landmark breast cancer trial has shown radiation therapy may be safely omitted from treatment for some people.
Common drug could help slow Type 1 diabetes
07 December 2023
A drug used to treat immune diseases could help suppress the progression of Type 1 diabetes.
The RMH and WEHI announce new $100m centre for immunology
21 November 2023
A world-leading immunology research centre that will look at the immune system in greater depth than ever before will be established here in Parkville, thanks to a generous $100m investment from the Snow Medical Research Foundation.
Cancer biobank nominated for City of Melbourne honour
02 November 2023
A cancer biobank with ties to the RMH has been named as a finalist in the Melbourne Awards, run by the City of Melbourne.
Spinal surgery performed using Victorian-first robotic machine
03 October 2023
A new robotic scanner that significantly improves the accuracy of complex surgeries is being used at the Royal Melbourne Hospital (RMH) – the first at a public hospital in Australia.
Researchers discover genes behind antibiotic resistance in deadly superbug infections
13 September 2023
Australian researchers have uncovered new genetic insights into Staphylococcus aureus, revealing what makes the bacterium so dangerous when it enters the blood.
The RMH neurologist receives $2 million to advance MND research and care
04 September 2023
The RMH neurologist and The Florey Institute researcher Dr Thanuja Dharmadasa has received funding for three grants in a record investment from FightMND.
SAD-AF: World-first trial looks at SSRIs and depression in atrial fibrillation
16 August 2023
Dr Youlin Koh
Experts say physiotherapy should be added to cancer patient recovery
03 August 2023
Researchers at the Royal Melbourne Hospital (RMH) say blood cancer patients should think about adding physiotherapy interventions to their treatment plans.
Studying effectiveness of AHSCT in highly active relapsing-remitting MS patients
28 July 2023
Researchers from the Royal Melbourne Hospital (RMH) have conducted a ground-breaking study comparing different treatment options for highly active relapsing-remitting multiple sclerosis (MS) patients who have shown limited response to conventional therapies.